Non-invasive Hemoglobin Monitoring in Outpatient Total Joint Arthroplasty

NCT05369325 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-07-27

No results posted yet for this study

Summary

This research is being done to better understand the accuracy of noninvasive hemoglobin tests on patients that recently underwent total joint arthroplasty.

Conditions

  • Total Joint Arthroplasty

Sponsors & Collaborators

Principal Investigators

  • Matthew Abdel, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-15
Primary Completion
2023-07-01
Completion
2023-07-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05369325 on ClinicalTrials.gov